THE CIGNA GROUP (CI) Stock Price, Quote, News and Overview
NYSE:CI - New York Stock Exchange, Inc. - US1255231003 - Common Stock - Currency: USD
CI Quote, Performance and Key Statistics
295.71
-2.57 (-0.86%)
The current stock price of CI is 295.71 USD. In the past month the price decreased by -5.94%. In the past year, price decreased by -11.95%.
CI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 9.74 | 78.38B | ||
| LH | LABCORP HOLDINGS INC | 16.55 | 20.40B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.16 | 18.63B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 14.05 | 15.58B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 113.65 | 12.43B | ||
| HIMS | HIMS & HERS HEALTH INC | 73.01 | 11.28B | ||
| DVA | DAVITA INC | 15.28 | 10.66B | ||
| CHE | CHEMED CORP | 19.15 | 6.60B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.76B | ||
| OPCH | OPTION CARE HEALTH INC | 23.77 | 4.83B | ||
| CRVL | CORVEL CORP | 51.34 | 4.81B | ||
| RDNT | RADNET INC | 273.76 | 4.31B |
Related stock screener links
About CI
Company Profile
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Company Info
THE CIGNA GROUP
900 Cottage Grove Road
Bloomfield CONNECTICUT 06002 US
CEO: David M. Cordani
Employees: 72398
Phone: 18602266000
THE CIGNA GROUP / CI FAQ
What is the stock price of THE CIGNA GROUP today?
The current stock price of CI is 295.71 USD. The price decreased by -0.86% in the last trading session.
What is the ticker symbol for THE CIGNA GROUP stock?
The exchange symbol of THE CIGNA GROUP is CI and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is CI stock listed?
CI stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for THE CIGNA GROUP stock?
34 analysts have analysed CI and the average price target is 383.04 USD. This implies a price increase of 29.53% is expected in the next year compared to the current price of 295.71. Check the THE CIGNA GROUP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is THE CIGNA GROUP worth?
THE CIGNA GROUP (CI) has a market capitalization of 79.00B USD. This makes CI a Large Cap stock.
How many employees does THE CIGNA GROUP have?
THE CIGNA GROUP (CI) currently has 72398 employees.
What are the support and resistance levels for THE CIGNA GROUP (CI) stock?
THE CIGNA GROUP (CI) has a support level at 286.99 and a resistance level at 313.92. Check the full technical report for a detailed analysis of CI support and resistance levels.
Is THE CIGNA GROUP (CI) expected to grow?
The Revenue of THE CIGNA GROUP (CI) is expected to grow by 5.37% in the next year. Check the estimates tab for more information on the CI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy THE CIGNA GROUP (CI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CI, evaluating the profitability, health, valuation and growth aspects
- THE CIGNA GROUP (CI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- THE CIGNA GROUP (CI) Sales and EPS estimates to see what analysts future expectations are.
- THE CIGNA GROUP (CI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- THE CIGNA GROUP (CI) Insider and Institutional Ownership to learn about the owners and their transactions.
- THE CIGNA GROUP (CI) Stock Chart to make your own analysis
- THE CIGNA GROUP (CI) Latest news and press-releases to stay up to date.
Does THE CIGNA GROUP (CI) stock pay dividends?
THE CIGNA GROUP (CI) has a dividend yield of 2.02%. The yearly dividend amount is currently 5.53. Check the full fundamental report for a detailed analysis of CI dividend history, reliability and sustainability.
When does THE CIGNA GROUP (CI) report earnings?
THE CIGNA GROUP (CI) will report earnings on 2025-07-31, before the market open.
What is the Price/Earnings (PE) ratio of THE CIGNA GROUP (CI)?
The PE ratio for THE CIGNA GROUP (CI) is 10.71. This is based on the reported non-GAAP earnings per share of 27.61 and the current share price of 295.71 USD. Check the full fundamental report for a full analysis of the valuation metrics for CI.
What is the Short Interest ratio of THE CIGNA GROUP (CI) stock?
The outstanding short interest for THE CIGNA GROUP (CI) is 1.11% of its float. Check the ownership tab for more information on the CI short interest.
CI Technical Analysis
CI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CI. While CI is still in line with the averages on profitability rating, there are concerns on its financial health.
CI Financial Highlights
Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 27.61. The EPS increased by 5.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.97% | ||
| ROA | 3.34% | ||
| ROE | 12.51% | ||
| Debt/Equity | 0.66 |
CI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 81% to CI. The Buy consensus is the average rating of analysts ratings from 34 analysts.
For the next year, analysts expect an EPS growth of 11.83% and a revenue growth 5.37% for CI